Samuel I. Rapaport
#131,056
Most Influential Person Now
Samuel I. Rapaport's AcademicInfluence.com Rankings
Samuel I. Rapaportphilosophy Degrees
Philosophy
#6365
World Rank
#9392
Historical Rank
Logic
#3540
World Rank
#4720
Historical Rank
Samuel I. Rapaportbiology Degrees
Biology
#8645
World Rank
#11755
Historical Rank
Biochemistry
#1261
World Rank
#1380
Historical Rank
Download Badge
Philosophy Biology
Why Is Samuel I. Rapaport Influential?
(Suggest an Edit or Addition)Samuel I. Rapaport's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies. (1961) (1036)
- Thrombosis in patients with the lupus anticoagulant. (1980) (524)
- Homozygous protein C deficiency manifested by massive venous thrombosis in the newborn. (1984) (444)
- The Tissue Factor Pathway: How It Has Become a “Prima Ballerina” (1995) (434)
- A simple, specific one-stage prothrombin assay using Russell's viper venom in cephalin suspension. (1955) (264)
- Defibrination after brain-tissue destruction: A serious complication of head injury. (1974) (232)
- Acquired inhibitors of blood coagulation. (1972) (230)
- A simplified procedure for purification of human prothrombin, factor IX and factor X. (1981) (219)
- Coumarin necrosis associated with hereditary protein C deficiency. (1984) (199)
- Depletion of extrinsic pathway inhibitor (EPI) sensitizes rabbits to disseminated intravascular coagulation induced with tissue factor: evidence supporting a physiologic role for EPI as a natural anticoagulant. (1991) (195)
- A mechanism for the hypoprothrombinemia of the acquired hypoprothrombinemia-lupus anticoagulant syndrome. (1983) (192)
- The importance of activation of antihemophilic globulin and proaccelerin by traces of thrombin in the generation of intrinsic prothrombinase activity. (1963) (182)
- Activation of human factor VII in plasma and in purified systems: roles of activated factor IX, kallikrein, and activated factor XII. (1979) (174)
- Isolation and characterization of human factor VII. Activation of factor VII by factor Xa. (1981) (172)
- The basalis of the primate endometrium: a bifunctional germinal compartment. (1989) (167)
- Inhibition of tissue factor/factor VIIa activity in plasma requires factor X and an additional plasma component. (1985) (161)
- The mode of inheritance of PTA deficiency: evidence for the existence of major PTA deficiency and minor PTA deficiency. (1961) (160)
- A simple, specific one-stage assay for plasma thromboplastin antecedent activity. (1961) (130)
- A plasma coagulation defect in systemic lupus erythematosus arising from hypoprothrombinemia combined with antiprothrombinase activity. (1960) (127)
- Osmotic blood-brain barrier disruption. Computerized tomographic monitoring of chemotherapeutic agent delivery. (1979) (125)
- Correction of Excessive Anticoagulation with Low-Dose Oral Vitamin K1 (1997) (125)
- Clinical significance of antibodies to bovine and human thrombin and factor V after surgical use of bovine thrombin. (1992) (123)
- Separation from Russell's viper venom of one fraction reacting with factor X and another reacting with factor V. (1969) (123)
- Immunodepletion of extrinsic pathway inhibitor sensitizes rabbits to endotoxin-induced intravascular coagulation and the generalized Shwartzman reaction. (1991) (119)
- Modifications of Extrinsic Pathway Inhibitor (EPI) and Factor Xa that Affect their Ability to Interact and to Inhibit Factor Vila/Tissue Factor: Evidence for a Two-Step Model of Inhibition (1988) (88)
- Activation Of Human Factor VII By Activated Factors IX And X In Purified Systems (1982) (81)
- Factor VII antibody-neutralizing material in hereditary and acquired factor VII deficiency. (1971) (81)
- Plasma clotting factors in chronic hepatocellular disease. (1960) (80)
- A CLINICAL AND FAMILY STUDY OF HEREDITARY PROCONVERTIN (FACTOR VII) DEFICIENCY. (1964) (76)
- Evidence that platelet accelerator (platelet factor 1) is adsorbed plasma proaccelerin. (1955) (76)
- The International Normalized Ratio (INR) for Monitoring Warfarin Therapy: Reliability and Relation to Other Monitoring Methods (1994) (74)
- Acquired hypoprothrombinemia due to non-neutralizing antibodies to prothrombin: mechanism and management. (1985) (74)
- Anti-hemophilic globulin levels in carriers of hemophilia A. (1960) (74)
- Hemophilia B: characterization of genetic variants and detection of carriers. (1977) (73)
- Trousseau's syndrome. (1993) (73)
- The effect of glass upon the activity of the various plasma clotting factors. (1955) (72)
- Hemophilia prophylaxis with factor VIII concentrate. (1970) (71)
- Radioimmunoassays for protein C and factor X. Plasma antigen levels in abnormal hemostatic states. (1984) (69)
- Factor V anticoagulants: clinical, biochemical, and immunological observations. (1970) (68)
- Hemophilia A: Polymorphism Detectable by a Factor VIII Antibody (1969) (68)
- Coexistent hypercoagulability and acute hypofibrinogenemia in a patient with prostatic carcinoma. (1959) (68)
- Binding of factor VIIa to tissue factor permits rapid antithrombin III/heparin inhibition of factor VIIa (1993) (66)
- THE IDENTIFICATION AND SYNTHESIS OF ACTIVATED PLASMA THROMBOPLASTIN COMPONENT (PTC'). (1963) (65)
- Albinism and abnormal platelet function. (1971) (65)
- Factor V activity of platelets: evidence for an activated factor V molecule and for a platelet activator (1977) (64)
- Use of a generally applicable tissue factor--dependent factor V assay to detect activated protein C-resistant factor Va in patients receiving warfarin and in patients with a lupus anticoagulant. (1995) (61)
- A monoclonal antibody to factor IX that inhibits the factor VIII:Ca potentiation of factor X activation. (1985) (57)
- The plasma protamine paracoagulation test: clinical and laboratory evaluation. (1972) (56)
- Hemostatic factors in rabbit limb lymph: relationship to mechanisms regulating extravascular coagulation. (1998) (54)
- Factor VIIa-catalyzed activation of factor X independent of tissue factor: its possible significance for control of hemophilic bleeding by infused factor VIIa (1990) (53)
- Introduction to Hematology (1971) (53)
- Studies of the Mechanism for Enhanced Cell Surface Factor VIIa/Tissue Factor Activation of Factor X on Fibroblast Monolayers after Their Exposure to N-Ethylmaleimide (1994) (51)
- Studies of the activation of factor VII bound to tissue factor. (1996) (47)
- Formation of Intrinsic Factor‐X‐Activator Activity, with Special Reference to the Role of Thrombin (1971) (45)
- CLOTTING FACTOR ASSAYS ON PLASMA FROM PATIENTS RECEIVING INTRAMUSCULAR OF SUBCUTANEOUS HEPARIN (1957) (45)
- Immunologic characterization of 12 factor VIII inhibitors. (1969) (44)
- Studies of the Factor Xa-Dependent Inhibitor of Factor VIIa/Tissue Factor (Extrinsic Pathway Inhibitor) from Cell Supernates of Cultured Human Umbilical Vein Endothelial Cells (1989) (43)
- Differences in the Interactions of Lupus Anticoagulant IgG with Human Prothrombin and Bovine Prothrombin (1995) (43)
- Syndrome of an acquired inhibitor of factor VIII responsive to cyclophosphamide and prednisone. (1981) (40)
- Separation of Plasma Thromboplastin Antecedent (PTA) and Hageman Factor (HF) from Human Plasma.∗ (1960) (40)
- Control of blood flow to the extremities at low ambient temperatures. (1949) (39)
- Lack of pathogenetic role of proteins C and S in thrombosis associated with asparaginase‐prednisone‐vincristine therapy for leukaemia (1986) (39)
- Cofactor of the “Lupus Anticoagulant” (1974) (37)
- Tissue Clearance as a Measure of Nutritive Blood Flow and the Effect of Lumbar Sympathetic Block upon Such Measures in Calf Muscle (1952) (37)
- Platelets and Initiation of Intrinsic Clotting (1973) (37)
- An acquired inhibitor of fibrin stabilization associated with isoniazid therapy: clinical and biochemical observations. (1974) (36)
- Partial purification and characterization of extrinsic pathway inhibitor (the factor Xa-dependent plasma inhibitor of factor VIIa/tissue factor). (1987) (36)
- Functional Properties of Factor VIIa/Tissue Factor Formed with Purified Tissue Factor and with Tissue Factor Expressed on Cultured Endothelial Cells (1989) (36)
- The levels of antihemophilic globulin and proaccelerin in fresh and bank blood. (1959) (34)
- A procedure for isolation of human protein C and protein S as by-products of the purification of factors VII, IX, X and prothrombin. (1983) (32)
- Factor XI activity and factor XI antigen in homozygous and heterozygous factor XI deficiency (1976) (31)
- Bleeding times and platelet aggregation after analgesics in hemophilia. (1972) (30)
- The clotting action of Russell viper venom. (1954) (30)
- Regulation of the Tissue Factor Pathway (1991) (28)
- Purification and Properties of an Abnormal Blood Coagulation Factor IX (Factor IXBm)/Kinetics of Its Inhibition of Factor X Activation by Factor VII and Bovine Tissue Factor (1981) (27)
- Antibody-Induced Acute Factor X Deficiency: Clinical Manifestations and Properties of the Antibody (1994) (26)
- STARCH BLOCK ELECTROPHORESIS OF PLASMA AND SERUM CLOTTING FACTORS. SEPARATION OF ACTIVATED PTC (PTC). (1965) (26)
- Factor XI and Platelets: Evidence that Platelets Contain only Minimal Factor XI Activity and Antigen (1977) (23)
- Relation between levels of plasma thromboplastin component (PTC) and prothrombin times by the P&P and Quick methods in patients receiving warfarin. (1962) (22)
- Factor V inhibitor: report of a case, with comments on a possible effect of streptomycin. (1973) (22)
- Familial chronic lymphatic leukemia. (1952) (21)
- Factor XI activity and factor XI antigen in homozygous and heterozygous factor XI deficiency. (1976) (20)
- Independence of capillary filtration and tissue clearance. (1952) (19)
- Redetermination of the rate-limiting step in the activation of factor IX by factor XIa and by factor VIIa/tissue factor. Explanation for different electrophoretic radioactivity profiles obtained on activation of 3H- and 125I-labeled factor IX. (1983) (19)
- Increased factor 8 levels in suspected carriers of hemophilia A taking contraceptives by mouth. (1966) (18)
- Heparin-Releasable and Platelet Pools of Tissue Factor Pathway Inhibitor in Rabbits (1993) (17)
- Failure of Fibrinogen Degradation Products to Increase Plasma Fibrinogen in Rabbits 1 (1973) (17)
- The lipid inhibitor of brain; mechanism of its anticoagulant action and its comparison with the soybean inositol phosphatide inhibitor. (1954) (16)
- A sulfated rabbit endothelial cell glycoprotein that inhibits factor VIIa/tissue factor is functionally and immunologically identical to rabbit extrinsic pathway inhibitor (EPI). (1991) (16)
- The Effect of Smoking upon Blood Flow in the Sympathectomized Limb (1950) (15)
- Enzymatic evaluation of therapeutic agents in cancer (1951) (15)
- History of Classical Hemophilia in a New England Family (1962) (14)
- Plasma Thromboplastin Antecedent Levels in Patients Receiving Coumarin Anticoagulants and in Patients with Laennec's Cirrhosis.∗ (1961) (13)
- Mechanism for diminished tissue factor expression by endothelial cells cultured with heparin binding growth factor-1 and heparin (1991) (13)
- Studies of factor Xa/phospholipid-induced intravascular coagulation in rabbits. Effects of immunodepletion of tissue factor pathway inhibitor. (1993) (13)
- Properties of factor VIIa/tissue factor complexes in an umbilical vein model (1990) (11)
- A plasma protein C activity assay suitable for a clinical laboratory. Its use to measure activity in hereditary and acquired deficiency states. (1987) (11)
- Evidence suggestive of activation of the intrinsic pathway of blood coagulation after injection of factor Xa/phospholipid into rabbits. (1995) (11)
- The coagulant activity of Russel viper venom. (1954) (10)
- The increased coagulability of plasma exposed to glass. (1954) (9)
- Pulmonary Lesions of Disseminated Lupus Erythematosus (1953) (9)
- The effect of immunodepletion of antithrombin III on the response of rabbits to Russell's viper venom-induced activation of factor X. (1997) (7)
- Evidence that glass increases plasma PTA activity. (1958) (7)
- The familial occurrence of chronic lymphocytic leukemia and multiple myeloma. (1960) (7)
- Fibrinogen Response to Turpentine and Endotoxin in Busulfan-Treated Rabbits (1976) (7)
- Clotting factor abnormalities in chronic liver disease. (1957) (6)
- Biophysical requirements for the ventilation of clothing. (1949) (6)
- Anti-Heparin Activity of Erythrocyte Hemolysate.∗ (1957) (6)
- Effects of Thorotrast upon the Reactivity and Intravascular Disappearance Rate of Fibrinogen in the Rabbit∗ (1968) (5)
- Reliability of a Modified Tissue Factor-Dependent Factor V Assay for Activated Protein C Resistant Factor Va Using a Calcium-Containing Thromboplastin (1997) (5)
- PANEL DISCUSSION. II. THE CLINICAL USAGE OF HEPARIN. (1964) (4)
- Isolation and Properties of the Abnormal Factor IX Molecule of Hemophilia BM (1977) (4)
- The activation of factor IX by the tissue factor pathway. (1981) (4)
- A novel clotting assay for quantitation of plasma prothrombin (factor II) using Echis multisquamatus venom. (1999) (4)
- The biochemistry of thromboplastin, its formation and action. (1954) (4)
- Paroxysmal nocturnal hemoglobinuria: case report with comments upon the urinary iron loss. (1956) (4)
- Clinically intermediate thalassemia due to hypersplenism complicating thalassemia minor; a case report illustrating relief of anemia by splenectomy. (1957) (3)
- The antihemophilic globulin in plasma; content of freshly frozen single-donor plasma units prepared by the Los Angeles Red Cross Blood Center. (1960) (3)
- Infectious Mononucleosis. An Analysis of Forty. Three Cases. (1948) (3)
- Heterogeneity in human prothrombin: analysis of cause. (1981) (3)
- Hemophilia polymorphism--the genetic plot thickens. (1969) (3)
- Hemophilia A: polymorphism detectable by a factor 8 antibody. (1969) (3)
- Hematologic effects of endotoxin on the macaque monkey. (1971) (3)
- Hemophilia B: Genetic Variants and Carrier Detection (1977) (3)
- Protac, a commercially available protein C activator from the venom of Agkistrodon contortrix contortrix, can activate factor V and factor VIII. (1997) (3)
- Physiological protection of the extremities from severe cold. (1948) (2)
- BLOOD COAGULATION: BIOCHEMICAL, PHYSIOLOGICAL AND CLINICAL CONSIDERATIONS (1968) (2)
- PTA (factor XI) levels after transfusion in patients with PTA deficiency. (1965) (2)
- Failure to Provoke the Local Shwartzman Reaction with Thrombin.∗ (1967) (2)
- Nonpalpable Testes in Young Boys: Evaluation With MR Imaging (1989) (1)
- an additional plasma component Inhibition of tissue factor/factor VIIa activity in plasma requires factor X and (2011) (1)
- Subject Index, Vol. 26 (suppl 1), 1996 (1996) (1)
- Result of sympathetic block on effective blood flow through calf muscle (1951) (1)
- Failure of Heparin, Epsilon Aminocaproic Acid, or Both Agents to Prevent Increased Fibrinogen Levels After Endotoxin in Rabbits 1 (1973) (1)
- Nutritional heart disease. (1950) (1)
- Editorial: Venous thrombosis--newer diagnostic and therapeutic approaches. (1974) (0)
- Isolation and Characterization of Human Factor VI 1 ACTIVATION OF FACTOR VI 1 (2001) (0)
- Heterogeneity in Human Prothrombin : Analysis of Cause 886 Blood (2005) (0)
- History of Classical Hemophilia in a (2017) (0)
- PANEL DISCUSSION. I. STRUCTURE AND PHARMACOLOGY OF HEPARIN. (1964) (0)
- Title Page / Table of Contents, Vol. 26, Supplement 1, 1996 (1996) (0)
- The physiological basis for the internal ventilation of clothing. (1948) (0)
- Hemostatic mechanisms in thrombogenesis: implications for therapy. (1970) (0)
- [Not Available]. (1947) (0)
- Hemostatic factors in rabbit limb lymph: relationship to mechanisms regulating extravascular coagulation. (1998) (0)
- Research in medical schools--a personal view. (1974) (0)
- factor XI deficiency Factor XI activity and factor XI antigen in homozygous and heterozygous (2011) (0)
- prothrombin: mechanism and management Acquired hypoprothrombinemia due to non-neutralizing antibodies to (2011) (0)
- Infectious mononucleosis; an analysis of 43 cases. (1948) (0)
- cells cultured with heparin binding growth factor-1 and heparin Mechanism for diminished tissue factor expression by endothelial (2011) (0)
- Activation of Factor IX by the reac Factor VII: Additional pathway foi (bypass of activated Factor XI/assay for activated Factor IX) (2016) (0)
- mechanisms regulating extravascular coagulation Hemostatic factors in rabbit limb lymph: relationship to (2016) (0)
- Thrombosis in the antiphospholipid-antibody syndrome. (1995) (0)
- INTRODUCTION (1975) (0)
- Structure and pharmacology of heparin (1964) (0)
- hypoprothrombinemia-lupus anticoagulant syndrome A mechanism for the hypoprothrombinemia of the acquired (2011) (0)
- The mandatory role of lipid in the interaction of factors 8 and 9. (1966) (0)
- Kinetics of the Inhibitory Effect of Factor IXBm in the Activation of Factor X by Factor VII and Bovine Tissue Factor (1979) (0)
- Thrombotic Thrombocytopenic Purpura (2020) (0)
- Shwartzman reaction endotoxin-induced intravascular coagulation and the generalized Immunodepletion of extrinsic pathway inhibitor sensitizes rabbits to (2011) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Samuel I. Rapaport?
Samuel I. Rapaport is affiliated with the following schools:
